Bang & Olufsen Medicom And AstraZeneca PLC Enter Agreement On New Patient Compliance Monitoring Device

Copenhagen September 4, 2006. Bang & Olufsen Medicom, an innovative drug delivery device solutions provider for the pharmaceutical industry, has announced that it has entered into an agreement with AstraZeneca AB on the development of a new patient monitor that measures patient compliance. The companies have signed the agreement to develop an electronic device that will be used in clinical studies. The device will be designed to register if patients take their medication correctly – and thereby measure patient compliance. Details of the agreement are confidential.

Back to news